PMS-DICLOFENAC
As listed in the register: PMS-DICLOFENAC
50 mg · tablet (delayed-release)
- Prescription only
- Muscles, joints and bones
- Active substance
- Diclofenac Sodium
- Used in
- Muscles, joints and bones
- Made by
- Pharmascience Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (diclofenac sodium). It describes the substance, not this Bulgarian product — its uses and doses can differ.
Diclofenac has analgesic, anti-inflammatory, and antipyretic properties.
The mechanism of action of diclofenac, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2).
Little or no free unchanged diclofenac is excreted in the urine.
Food has no significant effect on the extent of diclofenac absorption.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-02-06
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (diclofenac sodium). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS Cardiovascular Thrombotic Events Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal.
- Diclofenac sodium delayed-release tablets are contraindicated in the following patients: Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product ( see WARNINGS; Anaphylactic Reactions, Serious Skin Reactions ).
- History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs.
- Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients ( see WARNINGS; Anaphylactic Reaction, Exacerbation of Asthma Related to Aspirin Sensitivity ).
- In the setting of coronary artery bypass graft (CABG) surgery ( see Warnings; Cardiovascular Thrombotic Events ).
The most frequently reported adverse experiences occurring in approximately 1%-10% of patients are: Gastrointestinal experiences including: abdominal pain, constipation, diarrhea, dyspepsia, flatulence, gross bleeding/perforation, heartburn, nausea, GI ulcers (gastric/duodenal) and vomiting.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States60 matching products
Bulgaria3 matching products
Spain10 matching products
- DICLOFENACO NORMON 50 mg · comprimido dispersable2 makers
- DOLOTREN 50 mg · comprimido dispersable2 makers
- DICLOFENACO ALTER 50 mg · comprimido gastrorresistente
- DICLOFENACO ARISTO 50 mg · comprimido gastrorresistente
- DICLOFENACO CINFA 50 mg · comprimido gastrorresistente
- DICLOFENACO LLORENS 50 mg · comprimido
- DICLOFENACO PENSA 50 mg · comprimido
- VOLTAREN 50 mg · comprimido gastrorresistente
Netherlands3 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Pharmascience Inc |
|---|---|
| Active substance | Diclofenac Sodium |
| Used in | Muscles, joints and bones |
| Strength | 50 mg |
| Form | tablet (delayed-release) |
| Classification | M01AB05 · Muscles, joints and bones |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02302624 |
| DPD drug code | 78792 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.